Health Cor Management, L.P. Vertex Pharmaceuticals Inc Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $23.1 Million - $29.1 Million	-130,290 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $2.24 Million - $2.5 Million	12,330 Added 10.45%	130,290 $23.6 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $103 Million - $121 Million	-548,500 Reduced 82.3%	117,960 $23.8 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $17.2 Million - $20.1 Million	83,170 Added 14.26%	666,460 $143 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $45.7 Million - $61 Million	220,900 Added 60.96%	583,290 $138 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $86.1 Million - $102 Million	336,770 Added 1314.48%	362,390 $98.6 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $5.78 Million - $7.58 Million	25,620 New	25,620 $7.44 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $13.2 Million - $16.3 Million	-65,860 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $102 Million - $137 Million	-613,830 Reduced 90.31%	65,860 $14.4 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $23.5 Million - $26.4 Million	141,250 Added 26.23%	679,690 $115 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $32.9 Million - $38 Million	199,670 Added 58.94%	538,440 $98.7 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $23.9 Million - $28.4 Million	145,960 Added 75.7%	338,770 $62.3 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $23.2 Million - $29.4 Million	-152,740 Reduced 44.2%	192,810 $32 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $21.8 Million - $27.6 Million	143,370 Added 70.91%	345,550 $58.7 Million
Q3 2018 Nov 15, 2018	SELL	$167.73 - $192.74 $24 Million - $27.6 Million	-143,370 Reduced 41.49%	202,180 $39 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $28.5 Million - $33.3 Million	195,760 Added 130.69%	345,550 $58.7 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $87.2 Million - $102 Million	-575,210 Reduced 79.34%	149,790 $24.4 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $94.7 Million - $107 Million	690,050 Added 1974.39%	725,000 $109 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $5.18 Million - $5.67 Million	34,950	34,950 $5.31 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

Capital World Investors Los Angeles, CA

26.7M
Shares

$12.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$10.6 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.87 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.43 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$3.95 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Account